Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
A spidroin-derived solubility tag enables controlled aggregation of a designed amyloid protein
Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Neurogeriatr, Huddinge, Sweden..
Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Neurogeriatr, Huddinge, Sweden..
Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Neurogeriatr, Huddinge, Sweden..
Latvian Inst Organ Synth, Dept Phys Organ Chem, Riga, Latvia..
Visa övriga samt affilieringar
2018 (Engelska)Ingår i: The FEBS Journal, ISSN 1742-464X, E-ISSN 1742-4658, Vol. 285, nr 10, s. 1873-1885Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Amyloidogenesis is associated with more than 30 diseases, but the molecular mechanisms involved in cell toxicity and fibril formation remain largely unknown. The inherent tendency of amyloid-forming proteins to aggregate renders expression, purification, and experimental studies challenging. NT* is a solubility tag derived from a spider silk protein that was recently introduced for the production of several aggregation-prone peptides and proteins at high yields. Herein, we investigate whether fusion to NT* can prevent amyloid fibril formation and enable controlled aggregation for experimental studies. As an example of an amyloidogenic protein, we chose the de novo-designed polypeptide 17. The fusion protein NT*-17 was recombinantly expressed in Escherichia coli to produce high amounts of soluble and mostly monomeric protein. Structural analysis showed that 17 is kept in a largely unstructured conformation in fusion with NT*. After proteolytic release, 17 adopts a -sheet conformation in a pH- and salt-dependent manner and assembles into amyloid-like fibrils. The ability of NT* to prevent premature aggregation and to enable structural studies of prefibrillar states may facilitate investigation of proteins involved in amyloid diseases.

Ort, förlag, år, upplaga, sidor
WILEY , 2018. Vol. 285, nr 10, s. 1873-1885
Nyckelord [en]
amyloid disease, fibril formation, model protein, protein assembly, protein domain
Nationell ämneskategori
Biokemi och molekylärbiologi
Identifikatorer
URN: urn:nbn:se:kth:diva-231232DOI: 10.1111/febs.14451ISI: 000434177700010PubMedID: 29604175Scopus ID: 2-s2.0-85045301719OAI: oai:DiVA.org:kth-231232DiVA, id: diva2:1228138
Anmärkning

QC 20180627

Tillgänglig från: 2018-06-27 Skapad: 2018-06-27 Senast uppdaterad: 2018-06-27Bibliografiskt granskad

Open Access i DiVA

Fulltext saknas i DiVA

Övriga länkar

Förlagets fulltextPubMedScopus

Personposter BETA

Purhonen, PasiHebert, Hans

Sök vidare i DiVA

Av författaren/redaktören
Purhonen, PasiHebert, Hans
Av organisationen
Skolan för kemi, bioteknologi och hälsa (CBH)
I samma tidskrift
The FEBS Journal
Biokemi och molekylärbiologi

Sök vidare utanför DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 65 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf